Answers are grounded in this paper and cite their sources.
Aim – of this study was to investigate the antiradical activity of diethyl 6-aryl-3,6-dihydrotetrazolo[1,5-a]pyrimidine-4,5-dicarboxylates and to determine the spatial structure of the lead compound. Materials and methods. The subjects of the study were 11 compounds of the diethyl 6-aryl-3,6-dihydrotetrazolo[1,5-a]pyrimidine-4,5-dicarboxylate series. Antiradical activity was assessed by indirect photoelectrocolorimetric determination of the stable radical 2,2-diphenyl-1-picrylhydrazyl (DPPH). The reaction mixture was prepared from 1 ml of a 0.3 mM DPPH solution and 200 μl of a mixture of an aliquot of a solution of the test compounds or trolox, dissolved in DMSO, 1 ml of TRIS hydrochloride (buffer solution with pH = 7.36) and 1 ml of 96% ethyl alcohol, and kept in a dark place for 30 minutes. Then, the optical density of the reaction mixture was determined at a wavelength of 517 nm using a spectrophotometer (SF-2000, OKB SPEKTR, Russia) with a layer thickness of 1 cm. Upon binding of the stable free radical DPPH, the color of the solution changes from violet to yellow or brown. Trolox, a water-soluble form of vitamin E, was used as a comparison standard. The spatial structure of the lead compound was studied by X-ray diffraction analysis (XRD). X-ray diffraction analysis was performed on an Xcalibur Ruby single-crystal diffractometer (Agilent Technologies) with a CCD detector (MoKα radiation, 295(2) K, ω-scanning with a 1° step). Results. The synthesized compounds exhibit weak antiradical activity. The free radical reduction values ranged from 0,34 to 51%, with compound VII exhibiting the highest antiradical activity. Its structure contains a methoxy group at the meta position of the phenyl ring. The spatial structure of the lead compound was determined. Conclusions. The obtained results indicate weak antiradical activity of the studied compounds. Further research is needed to identify the structure-activity relationship in the diethyl 6-aryl-3,6-dihydrotetrazolo[1,5-a]pyrimidine-4,5-dicarboxylate series for the targeted synthesis of antioxidants with an antiradical mechanism of action.
No takes yet. Share an insight, caveat, or question.
Shaikhutdinova et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: